A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory.
Arango NP, Brusco L, Mills Shaw KR, Chen K, Eterovic AK, Holla V, Johnson A, Litzenburger B, Khotskaya YB, Sanchez N, Bailey A, Zheng X, Horombe C, Kopetz S, Farhangfar CJ, Routbort M, Broaddus R, Bernstam EV, Mendelsohn J, Mills GB, Meric-Bernstam F.
Arango NP, et al. Among authors: mills shaw kr, mills gb.
Oncotarget. 2017 Jun 27;8(26):41806-41814. doi: 10.18632/oncotarget.16018.
Oncotarget. 2017.
PMID: 28415679
Free PMC article.